Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 2 |
| Jun 2026 | 1 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2024 Filed Aug 16, 2024 21:09 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionStock Units · Derivative | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022376 · form4.xml · derivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,155 Underlying: Common Stock · 1,020 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F2 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:09 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022376 · form4.xml · nonDerivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:07 UTC |
Jeffery Reuben IIIDirector
|
Exercise / conversionStock Units · Derivative | 1,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022375 · form4.xml · derivative · entry 2 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,884 Underlying: Common Stock · 1,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:07 UTC |
Jeffery Reuben IIIDirector
|
Exercise / conversionCommon Stock | 1,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022375 · form4.xml · nonDerivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:06 UTC |
Matos Rodriguez Felix V.Director
|
Exercise / conversionStock Units · Derivative | 556 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022374 · form4.xml · derivative · entry 2 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,281 Underlying: Common Stock · 556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:06 UTC |
Matos Rodriguez Felix V.Director
|
Exercise / conversionCommon Stock | 556 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022374 · form4.xml · nonDerivative · entry 1 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:04 UTC |
Churchill Dwight D.Director
|
Exercise / conversionStock Units · Derivative | 1,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022373 · form4.xml · derivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,645 Underlying: Common Stock · 1,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:04 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 1,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022373 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:03 UTC |
Ryan David ChristopherDirector
|
Exercise / conversionStock Units · Derivative | 545 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022372 · form4.xml · derivative · entry 2 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,065 Underlying: Common Stock · 545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F2 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:03 UTC |
Ryan David ChristopherDirector
|
Exercise / conversionCommon Stock | 545 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022372 · form4.xml · nonDerivative · entry 1 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:01 UTC |
Alvingham Karen L.Director
|
Exercise / conversionStock Units · Derivative | 928 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022371 · form4.xml · derivative · entry 3 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,238 Underlying: Common Stock · 928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2021-2027. F3 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:01 UTC |
Alvingham Karen L.Director
|
Tax withholdingCommon Stock | 72 | $171.98 | $12,382.56 |
DisclosureSEC source: 0001127602-24-022371 · form4.xml · nonDerivative · entry 2 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,769 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:01 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 928 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022371 · form4.xml · nonDerivative · entry 1 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2021-2027. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,679 | $0.00 Strike: $69.63 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 13 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560 Underlying: Common Stock · 1,679 shares Expires 2027-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,958 | $0.00 Strike: $82.07 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 12 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,958 shares Expires 2027-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,661 | $0.00 Strike: $86.78 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 11 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,661 shares Expires 2026-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,787 | $0.00 Strike: $110.02 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 10 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,787 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,353 | $0.00 Strike: $160.01 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 9 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,353 shares Expires 2025-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Tax withholdingCommon Stock | 5,787 | $185.62 | $1,074,182.94 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · nonDerivative · entry 6 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,913 Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 1,679 | $69.63 | $116,908.77 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · nonDerivative · entry 5 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 2,958 | $82.07 | $242,763.06 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · nonDerivative · entry 4 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 2,661 | $86.78 | $230,921.58 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · nonDerivative · entry 3 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 1,787 | $110.02 | $196,605.74 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · nonDerivative · entry 2 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 1,353 | $160.01 | $216,493.53 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · nonDerivative · entry 1 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:46 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $86.78 | $0.00 |
DisclosureSEC source: 0001127602-24-021268 · form4.xml · derivative · entry 5 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,361 Underlying: Common Stock · 1,300 shares Expires 2026-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:46 UTC |
Palandjian Tracy P.Director
|
Tax withholdingCommon Stock | 608 | $185.62 | $112,856.96 |
DisclosureSEC source: 0001127602-24-021268 · form4.xml · nonDerivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,913 Read SEC document |
| July 31, 2024 Filed Jul 31, 2024 22:46 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 1,300 | $86.78 | $112,814.00 |
DisclosureSEC source: 0001127602-24-021268 · form4.xml · nonDerivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
GrantDeferred Stock Units · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 8 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372 Underlying: Common Stock · 372 shares Expires not disclosed F2 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:52 UTC |
Alvingham Karen L.Director
|
GrantRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021272 · form4.xml · derivative · entry 7 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:49 UTC |
Matos Rodriguez Felix V.Director
|
GrantRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021271 · form4.xml · derivative · entry 1 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:47 UTC |
Ryan David ChristopherDirector
|
GrantDeferred Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021269 · form4.xml · derivative · entry 2 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380 Underlying: Common Stock · 380 shares Expires not disclosed F2 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:47 UTC |
Ryan David ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021269 · form4.xml · derivative · entry 1 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:46 UTC |
Palandjian Tracy P.Director
|
GrantDeferred Stock Units · Derivative | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021268 · form4.xml · derivative · entry 4 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426 Underlying: Common Stock · 426 shares Expires not disclosed F2 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:46 UTC |
Palandjian Tracy P.Director
|
GrantRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021268 · form4.xml · derivative · entry 3 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:48 UTC |
STARR LOREN MDirector
|
GrantDeferred Stock Units · Derivative | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021270 · form4.xml · derivative · entry 2 STARR LOREN M · CIK 0001217495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428 Underlying: Common Stock · 428 shares Expires not disclosed F2 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:48 UTC |
STARR LOREN MDirector
|
GrantRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021270 · form4.xml · derivative · entry 1 STARR LOREN M · CIK 0001217495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:45 UTC |
Jeffery Reuben IIIDirector
|
GrantRestricted Stock Units · Derivative | 816 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021267 · form4.xml · derivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 816 Underlying: Common Stock · 816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:43 UTC |
Churchill Dwight D.Director
|
GrantRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021266 · form4.xml · derivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544 Underlying: Common Stock · 544 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:42 UTC |
FRANQUI ANNETTEDirector
|
GrantRestricted Stock Units · Derivative | 664 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021265 · form4.xml · derivative · entry 1 Franqui Annette · CIK 0001849146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664 Underlying: Common Stock · 664 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2025. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,679 | $0.00 Strike: $69.63 | $0.00 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · derivative · entry 9 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560 Underlying: Common Stock · 1,679 shares Expires 2027-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,958 | $0.00 Strike: $82.07 | $0.00 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · derivative · entry 8 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,958 shares Expires 2027-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,661 | $0.00 Strike: $86.78 | $0.00 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · derivative · entry 7 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,661 shares Expires 2026-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,787 | $0.00 Strike: $110.02 | $0.00 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · derivative · entry 6 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,787 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Tax withholdingCommon Stock | 4,702 | $167.47 | $787,443.94 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · nonDerivative · entry 5 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,403 Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 1,679 | $69.63 | $116,908.77 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · nonDerivative · entry 4 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 2,958 | $82.07 | $242,763.06 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · nonDerivative · entry 3 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 2,661 | $86.78 | $230,921.58 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · nonDerivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:03 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 1,787 | $110.02 | $196,605.74 |
DisclosureSEC source: 0001127602-24-011403 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:46 UTC |
Horgen Jay C.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $74.49 | $0.00 |
DisclosureSEC source: 0001127602-24-009061 · form4.xml · derivative · entry 7 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2026-08-15 F5 · derivative.exercise_date: Reflects an option award granted in August 2019, which vests on August 15, 2024 following the satisfaction of applicable performance and service conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:46 UTC |
Horgen Jay C.Director · President and CEO
|
GrantStock Units · Derivative | 15,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009061 · form4.xml · derivative · entry 6 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,702 Underlying: Common Stock · 15,702 shares Expires not disclosed F4 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. F4 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. F4 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.